BREAST Cancers Project:
Objective: Development and validation of new biomarkers, as well as diagnostic and therapeutic management support algorithms.
Patients involved: Patients who underwent breast cancer surgery between 2020 and 2025.

LUNG Cancers Project:
Objective: Development and validation of new biomarkers, as well as diagnostic and therapeutic management support algorithms.
Patients involved: Patients who underwent lung cancer surgery between 2016 and 2025.

COLON Cancers Project:
Objective: Development and validation of new biomarkers, as well as diagnostic and therapeutic management support algorithms.
Patients involved: Patients who underwent lung cancer surgery between 2020 and 2025.

BLADDER Cancers Project:
Objective: Development and validation of new biomarkers, as well as diagnostic and therapeutic management support algorithms.
Patients involved: Patients who underwent lung cancer surgery between 2020 and 2025.